Pharsight

Amlodipine Besylate generic

amlodipine besylate is a drug that is owned by Synthon Pharms. The active ingredient of this drug is amlodipine besylate itself. It got its first market authorization on 27 September, 2007 and currently holds 1 drug patent. However, it is noteworthy that out of these, 1 patent has already expired.

When will Amlodipine Besylate generic be available?

The Amlodipine Besylate generic is expected to be available after 20 November, 2022. This is because its last patent, US6828339, titled 'Amlodipine salt forms and processes for preparing them', is set to expire on 20 November, 2022.

Amlodipine Besylate uses

amlodipine besylate comes in tablet, and orally disintegrating;oral dosage forms. Thanks to amlodipine besylate—the active ingredient—this drug can be very effective.

Amlodipine Besylate patent expiration

Amlodipine Besylate, which is set to have a generic soon, currently holds 1 drug patent. However, 1 of these has already expired. The last patent, US6828339, will expire on 20 November, 2022. Below is the detail of the patent:

Amlodipine Besylate dosage

Want to ask something?